Amgen Inc, 9.58%

Gilead Sciences Inc, 8.2%

Vertex Pharmaceuticals Inc, 7.23%

Regeneron Pharmaceuticals Inc, 6.71%

Moderna Inc, 5.8%

The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.

iShares J.P. Morgan ESG $ EM Bond UCITS ETF USD (Acc)

Lyxor MSCI World ESG Leaders Extra (DR) UCITS ETF Acc

HSBC DEV WORLD SUSTAINABLE E

L&G US Equity (Responsible Exclusions) UCITS ETF

Xtrackers (IE) Public Limited Company - Xtrackers MSCI World Momentum UCITS ETF